HZNP NASDAQ
Horizon Therapeutics Public Limited Company
1W: +0.3%
1M: +0.8%
3M: +12.9%
1Y: +71.3%
3Y: +45.2%
5Y: +513.7%
$116.30
Last traded 2023-10-09 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$9.1B
+5.0% ▲
5Y CAGR: +17.0%
Total Liabilities
$4.0B
+0.9% ▲
5Y CAGR: +4.9%
Shareholders Equity
$5.1B
+8.6% ▲
5Y CAGR: +38.6%
Cash & Investments
$2.4B
+48.9% ▲
5Y CAGR: +25.6%
Total Debt
$2.6B
-0.3% ▼
5Y CAGR: +6.1%
Net Debt
$210M
-78.8% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $959M | $1.1B | $2.1B | $1.6B | $2.4B |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $959M | $1.1B | $2.1B | $1.6B | $2.4B |
| Net Receivables | $465M | $409M | $660M | $633M | $676M |
| Inventory | $51M | $54M | $75M | $226M | $170M |
| Other Current Assets | $61M | $147M | $256M | $361M | $449M |
| Total Current Assets | $1.5B | $1.7B | $3.1B | $2.8B | $3.7B |
| Property, Plant & Equip. | $20M | $30M | $189M | $292M | $341M |
| Goodwill & Intangibles | $2.6B | $2.1B | $2.2B | $4.9B | $4.5B |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $23M | $48M | $56M | $141M | $204M |
| Total Non-Current Assets | $2.6B | $2.7B | $3.0B | $5.9B | $5.5B |
| Total Assets | $4.1B | $4.4B | $6.1B | $8.7B | $9.1B |
| — Liabilities — | |||||
| Accounts Payable | $30M | $22M | $38M | $30M | $156M |
| Short-Term Debt | $0 | $0 | $0 | $16M | $16M |
| Deferred Revenue | $5M | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $727M | $702M | $838M | $840M | $777M |
| Total Current Liabilities | $762M | $723M | $876M | $887M | $949M |
| Long-Term Debt | $1.6B | $1.0B | $1.0B | $2.6B | $2.5B |
| Other Non-Current Liab. | $672M | $432M | $102M | $173M | $204M |
| Total Non-Current Liabilities | $2.3B | $1.5B | $1.2B | $3.1B | $3.1B |
| Total Liabilities | $3.1B | $2.3B | $2.0B | $4.0B | $4.0B |
| — Equity — | |||||
| Common Stock | $17K | $19K | $22K | $23K | $23K |
| Retained Earnings | -$1.3B | -$606M | -$216M | $319M | $590M |
| Accumulated OCI | -$2M | -$2M | -$145K | -$15M | $13M |
| Total Stockholders Equity | $1.1B | $2.2B | $4.0B | $4.7B | $5.1B |
| Total Liabilities & Equity | $4.1B | $4.4B | $6.1B | $8.7B | $9.1B |
| — Key Metrics — | |||||
| Total Debt | $1.9B | $1.4B | $1.0B | $2.6B | $2.6B |
| Net Debt | $938M | $277M | -$1.1B | $991M | $210M |
| Total Investments | $0 | $0 | $0 | $0 | $0 |